Endoscopic treatment of anastomotic oesophageal stricture: a randomised study comparing initial dilation by electrocautery with Savary bougies with electrocautery

ISRCTN ISRCTN81239664
DOI https://doi.org/10.1186/ISRCTN81239664
Secondary identifying numbers NTR931
Submission date
11/04/2007
Registration date
11/04/2007
Last edited
20/01/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr M L Hordijk
Scientific

Department of Gastroenterology and Hepatology
Erasmus Medical Centre Rotterdam
University Hospital
P.O. Box 2040
Rotterdam
3000 CA
Netherlands

Phone + 31 (0)10 463 5946
Email m.hordijk@erasmusmc.nl

Study information

Study designRandomised controlled parallel group double blinded multicentre trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesAnastomotic strictures are common after oesophageal resection. These strictures often need multiple dilation procedures with Savary bougies, and some even fail despite many dilations. Based on the literature and our pilot study of electrocautery therapy of refractory benign oesophageal stenosis, electrocautery treatment is safe, and may provide an excellent alternative for primary treatment of oesophageal strictures.

A prospective randomised controlled trial is needed to compare dilation therapy with Savary bouginage with electrocautery therapy for the primary treatment of these strictures.
Ethics approval(s)Approval received from the METC Erasmus MC on the 12th May 2004 (ref: MEC 238.671/2004/8).
Health condition(s) or problem(s) studiedAnastomotic oesophageal stricture
InterventionPatients will either undergo dilation with Savary bougies, or primary electrocautery.

An upper gastrointestinal endoscopy will be performed. The postoperative stenosis will be inspected and the diameter of the stenosis will be estimated by using the diameter of the endoscope (9.5 mm). These stenoses are usually located at 17 to 20 cm from the incisors.

For endoscopic bougie dilation of the stricture, a guide wire will be placed in the stomach, followed by removal of the endoscope and passage of Savary Gilliard bougies of increasing diameter over the guide wire according to standard procedures to a diameter of minimal of 16 mm and maximal 19 mm.

For endoscopic dilation of the strictures with electrocautery, the tip of the endoscope is positioned just proximal from the stenosis, and a needle knife catheter (Wilson Cook, Boston Scientific) is introduced through the working channel. Radial incisions are made in the stenotic ring with the needle knife catheter under direct visualisation. The required length of the cut is gauged according to the length of the stricture assumed by the endoscopist in the light of the membranous nature and the calibre of the stricture. The depth of the incision (estimated using the length of the needle knife as a comparator) is not deeper than 4 mm. The length of the incision is dosed to completely remove the rim of the stenosis.

In case of recurrent stenosis, dilation therapy will be repeated with the same modality as was used at baseline. Recurrent stenosis is defined as no passage or only passage with pressure of the endoscope (diameter 9.5 mm).
Intervention typeProcedure/Surgery
Primary outcome measureThis study aims to compare the efficacy of Savary dilation versus endoscopic electrocautery treatment for the treatment of fibrotic anastomotic strictures after oesophageal resection.
1. The efficacy of therapy will be evaluated by means of objective and subjective criteria, which will be determined both before treatment and during follow-up after treatment
2. The objective criteria are obtained by standard items at endoscopy and body weight. Endoscopic evaluation of the stricture will take place at baseline, and will be repeated in case of recurrent or persistent symptoms
3. The European Organisation for Research and Treatment of Cancer (EORTC) health related Quality of Life Questionnaires, Short Form 36-question health survey (SF-36), Quality of Life Questionnaire on Cancer (QLQ C-30) (version 3) and Quality of Life Oesophageal Questionnaire (QLQ OES-18) are used to structure a quality of life questionnaire especially focused on benign oesophageal stenosis

All outcomes will be measured at zero, one, three and six months.
Secondary outcome measuresIs there a difference in the interval of retreatment between electrocautery and Savary bougies, because of stenosis of the anastomosis of the oesophagus?

All outcomes will be measured at zero, one, three and six months.
Overall study start date17/06/2004
Completion date01/09/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants62
Key inclusion criteriaSixty-two unselected consecutive patients with dysphagia due to a benign anastomotic stricture after transhiatal oesophagectomy with gastric tube reconstruction and cervical anastomosis will be included and randomised to either treatment arm. After informed consent, patients will either undergo dilation with Savary bougies, or primary electocautery.
Key exclusion criteria1. Oesophageal dilation with bougies or electrocautery is rarely contraindicated.
Patients should however not be dilated if they recently suffered from acute oesophageal perforation
2. Dilation is relatively contraindicated in the presence of:
2.1. a bleeding diathesis
2.2. severely compromised pulmonary function
2.3. severe or unstable cardiac disease, or in
2.4. patients with large thoracic aortic aneurysms
Date of first enrolment17/06/2004
Date of final enrolment01/09/2007

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Department of Gastroenterology and Hepatology
Rotterdam
3000 CA
Netherlands

Sponsor information

Erasmus Medical Centre (The Netherlands)
Hospital/treatment centre

Department of Hepatology and Gastroenterology
P.O. Box 2040
Rotterdam
3000 CA
Netherlands

Website http://www.erasmusmc.nl/
ROR logo "ROR" https://ror.org/018906e22

Funders

Funder type

Hospital/treatment centre

Erasmus Medical Centre (Netherlands)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/11/2009 Yes No